Sarepta Therapeutics Inc (SRPT) — Cash Flow Quality Index
Sarepta Therapeutics Inc (SRPT) has a Cash Flow Quality Index of -0.61x as of March 2026. Operating cash flow of $-202.68 Million is below net income of $330.96 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore SRPT cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sarepta Therapeutics Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Sarepta Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Sarepta Therapeutics Inc (SRPT) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Sarepta Therapeutics Inc (2024–2024)
Year-by-year earnings quality comparison for Sarepta Therapeutics Inc. For live market cap and the full company financial profile, see SRPT stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.87x | $-205.79 Million | $235.24 Million | — |